
Sri Kaustubha Pharma Private Limited
About Sri Kaustubha Pharma Private Limited
Data last updated:
Sri Kaustubha Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 May 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2015PTC098941.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Madhavi Mareddy and Mareddy Pera Reddy.
Its last annual general meeting (AGM) was held on 29 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at 8 – 3 – 678/60/301 Flat No. 301 Park View Apartments Plot No.60 Pragathi Nagar Yousuf Guda, Hyderabad, Telangana, India – 500045.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sri Kaustubha Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address8 – 3 – 678/60/301 Flat No. 301 Park View Apartments Plot No.60 Pragathi Nagar Yousuf Guda, Hyderabad, Telangana, India – 500045
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sri Kaustubha Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sri Kaustubha Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sri Kaustubha Pharma Private Limited, buy the company report.
Financials of Sri Kaustubha Pharma Private Limited
FY 2021 filings availableFinancial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sri Kaustubha Pharma Private Limited, buy the company report.
Board of directors of Sri Kaustubha Pharma Private Limited
Sri Kaustubha Pharma has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhavi Mareddy | Director | 15 May 2015 | 11 Years 5 Months | Current |
| Mareddy Pera Reddy | Director | 15 May 2015 | 11 Years 5 Months | Current |
| Mareddy Tanmayee Also directs: Infoniant Systems Private Limited | Director | 24 Nov 2017 | 8 Years 11 Months | Current |
| Mareddy Ramakotireddy | Director | 24 Nov 2017 | 8 Years 11 Months | Current |
Auditor
Sri Kaustubha Pharma Private Limited is audited by SURYANARAYANA REDDY & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SURYANARAYANA REDDY & CO | FY 2018 | 005752S |
Shareholding
The shareholding of Sri Kaustubha Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Sri Kaustubha Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sri Kaustubha Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sri Kaustubha Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sri Kaustubha Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sri Kaustubha Pharma Private Limited has 6 board changes on record since 2015: 4 appointments and 2 cessations. The latest: Mareddy Ramakotireddy ceased to be Additional Director on 29 Sep 2018.
Frequently asked questions
Sri Kaustubha Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 May 2015 (11+ years old) and is registered under CIN U24100TG2015PTC098941.
Sri Kaustubha Pharma has 4 current directors:
- Madhavi Mareddy - Director
- Mareddy Pera Reddy - Director
- Mareddy Tanmayee - Director
- Mareddy Ramakotireddy - Director
The latest financial statements of Sri Kaustubha Pharma on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 29 November 2021. Year-wise statements from FY 2016 are in the company report.
The CIN (Corporate Identification Number) of Sri Kaustubha Pharma is U24100TG2015PTC098941. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sri Kaustubha Pharma was incorporated on 15 May 2015, making it 11+ years old. It is registered with the Registrar of Companies, Hyderabad.
Mareddy Ramakotireddy ceased to be Additional Director on 29 Sep 2018. Mareddy Tanmayee ceased to be Additional Director on 29 Sep 2018. Mareddy Ramakotireddy was appointed as Director on 24 Nov 2017. Sri Kaustubha Pharma has 6 board changes on record in total.
The registered office of Sri Kaustubha Pharma is at 8 – 3 – 67860301 Flat No. 301 Park View Apartments Plot No.60 Pragathi Nagar Yousuf Guda, Hyderabad, Telangana, India – 500045.
Sri Kaustubha Pharma operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Sri Kaustubha Pharma is compliant as of 17 September 2026. The company is actively filing with the Registrar of Companies.
Sri Kaustubha Pharma can be reached at its registered office: 8 – 3 – 67860301 Flat No. 301 Park View Apartments Plot No.60 Pragathi Nagar Yousuf Guda, Hyderabad, Telangana, India – 500045.

